[Federal Register Volume 63, Number 81 (Tuesday, April 28, 1998)]
[Notices]
[Page 23294]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-11253]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Heart, Lung, and Blood Institute; Notice of Closed 
Meetings

    Pursuant to Section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
National Heart, Lung, and Blood Institute Special Emphasis Panel (SEP) 
meetings:

    Name of SEP: Cardiovascular Benefits of Soy Phytoestrogens.
    Date: May 4-5, 1998.
    Time: 7:00 p.m.
    Place: Holiday Inn, 2 Montgomery Village Avenue, Gaithersburg, 
Maryland 20879.
    Contact Person: Anthony M. Coelho, Ph.D, Two Rockledge Center, 
Room 7194, 6701 Rockledge Drive, Bethesda, MD 20892-7924, (301) 435-
0288.
    Purpose/Agenda: To review and evaluate grant applications.
    This notice is being published less than fifteen days prior to 
this meeting due to the urgent need to meet timing limitations 
imposed by the grant review and funding cycle.

    Name of SEP: Lipoprotein(a) Standardization Program (Telephone 
Conference Call).
    Date: May 20, 1998.
    Time: 2:00 p.m. EDT.
    Place:  Two Rockledge Center, Room 7214, 6701 Rockledge Drive, 
Bethesda, MD 20892.
    Contact Person: Camille King, Ph.D, Two Rockledge Center, Room 
7208A, 6701 Rockledge Drive, Bethesda, MD 20892-7924, (301) 435-
0321.
    Purpose/Agenda: To review and evaluate contract proposals.
    Name of SEP: Review of Independent Scientist Award (K02) and 
Mentored Clinical Scientist Development Award (K08) Applications.
    Date: June 15, 1998.
    Time: 8:00 a.m.
    Place: Key Bridge Marriott, 1401 Lee Highway, Arlington, 
Virginia 22209.
    Contact Person: S. Charles Selden, Ph.D, Two Rockledge Center, 
Room 7196, 6701 Rockledge Drive, Bethesda, MD 20892-7924, (301) 435-
0288.
    Purpose/Agenda: To review and evaluate grant applications.

    Name of SEP: Public Access Defribrillation (PAD-1) Clinical 
Trial.
    Date: June 23, 1998.
    Time: 8:00 p.m.
    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 
Bethesda, Maryland 20814.
    Contact Person: Joyce A Hunter, Ph.D, Two Rockledge Center, Room 
7192, 6701 Rockledge Drive, Bethesda, MD 20892-7924, (301) 435-0287.
    Purpose/Agenda: To review and evaluate contract proposals.
    These meetings will be closed in accordance with the provisions 
set forth in secs. 552b(c)(4) and 552b(c)(6), Title 5, U.S.C. 
Applications and/or proposals and the discussions could reveal 
confidential trade secrets or commercial property such as patentable 
material and personal information concerning individuals associated 
with the applications and/or proposals, the disclosure of which 
would constitute a clearly unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance Programs Nos. 93.837, Heart 
and Vascular Diseases Research; 93.838, Lung Diseases Research; and 
93.839, Blood Diseases and Resources Research, National Institutes 
of Health)

    Dated: April 21, 1998.
LaVeen Ponds,
Policy Analyst, NIH.
[FR Doc. 98-11253 Filed 4-27-98; 8:45 am]
BILLING CODE 4140-01-M